The 2023 Bial Prize in Biomedicine is awarded for international research into glioblastoma, an aggressive brain tumor, the foundation promoting the award, worth 300,000 euros, announced on Tuesday.
The study, signed by scientists from Germany, the US, the UK and Norway, was published on September 18, 2019 in the journal Nature and describes a direct communication channel between neurons and tumor cells, demonstrating that “glioblastomas are able to integrate into brain function” and thus progress , according to a statement from the Bial Foundation, which awards the biomedical prize in odd-numbered years.
According to the prize’s jury president, neuroscientist Ralph Adolph, quoted in the statement, the study represents “an important and surprising advance in understanding how brain cancer progresses by describing a new communication channel between neurons and the tumor,” suggesting “concrete pathways” to treatment.” .
The Bial Prize in Biomedicine recognizes work in the field of biomedicine published within the last 10 years that produces results of “exceptional quality and scientific significance.”
Created in 1994, the Bial Foundation, formed by representatives of the Portuguese pharmaceutical company of the same name and the Council of Rectors of Portuguese Universities, has “the mission of encouraging human scientific research, both from a physical and spiritual point of view.” glance.”
The 2021 edition of the Bial Biomedicine Prize recognized preclinical research into a Zika virus vaccine based on messenger RNA genetic technology currently used in Covid-19 vaccines.
The study, published in 2017, was conducted by a team led by American immunologist Drew Weissman and including Hungarian biochemist Katalin Karikó, vice president of BioNTech and the author of the patent on which the resulting Covid-19 vaccine is based. German biotechnology company and North American pharmaceutical company Pfizer.
Drew Weissman and Katalin Kariko were awarded the 2023 Nobel Prize in Medicine for biotechnological discoveries related to the creation of messenger RNA vaccines for Covid-19, the pandemic respiratory disease caused by the coronavirus SARS-CoV-2, first discovered in 2019 in the United States. China.
Author: Lusa
Source: CM Jornal
I’m Tifany Hawkins, a professional journalist with years of experience in news reporting. I currently work for a prominent news website and write articles for 24NewsReporters as an author. My primary focus is on economy-related stories, though I am also experienced in several other areas of journalism.